Iopofosine I 131 may improve survival in pediatric brain cancer
The experimental therapy iopofosine I 131Â may improve survival outcomes…
Gliomas are a group of brain tumors that arise from glial cells, a type of support cell of the central nervous system, or CNS, which comprises the brain and spinal cord. They make up about one-quarter of all tumors that start in the brain (primary brain tumors), occurring in about 6.6 per 100,000 people every year. They also account for more than 80% of all malignant, or cancerous, brain tumors.
Read moreTreatment for gliomas, a diverse group of tumors that form in the brain and spinal cord, can involve a variety of approaches, including surgery, radiation therapy, and chemotherapy, as well as a range of supportive treatments.
Read moreThe experimental therapy iopofosine I 131Â may improve survival outcomes…
The European Commission has approved Voranigo (vorasidenib) for…
Enrollment is now complete in a Phase 2b clinical…
The National Comprehensive Cancer Network (NCCN) has updated…
Researchers may have found a way to halt the…
Enrollment is now open in a U.S. clinical trial…